PLRX

Pliant Therapeutics, Inc. - Common Stock (PLRX)

About Pliant Therapeutics, Inc. - Common Stock (PLRX)

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Details

Daily high

$1.48

Daily low

$1.36

Price at open

$1.44

52 Week High

$16.10

52 Week Low

$1.10

Market cap

84.7M

Dividend yield

0.00%

Volume

561,221

Avg. volume

1.1M

P/E ratio

-.38

Pliant Therapeutics, Inc. - Common Stock News